Chen et al. successfully utilized an MSN/antibody complex to target NF-κB and catch the active NF-κB p65 subunit using p65 specific in the perinuclear region in head and neck squamous cell carcinoma. This evidence concerns the gene NFKB1 and head and neck squamous cell carcinoma.